Risk and clinical characteristics of spinal cord compression across different mucopolysaccharidosis types: A

Insung Kim1, Juyoung Sung1, Yoon Ji Ahn1

  • 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Medicine
|October 21, 2024
PubMed

Insights

Spinal cord compression (SCC) is common in mucopolysaccharidosis (MPS). Risk and causes of SCC vary by MPS type, necessitating individualized care for early detection and intervention.

Area of Science:

  • Medical Genetics
  • Neurology
  • Orthopedics

Background:

  • Mucopolysaccharidosis (MPS) involves glycosaminoglycan accumulation, leading to complications like spinal cord compression (SCC).
  • Limited data exists comparing SCC clinical features across diverse MPS types.
  • Understanding these variations is crucial for patient management.

Purpose of the Study:

  • To investigate the timing, location, and causes of SCC in MPS patients.
  • To compare the risk and clinical characteristics of SCC across different MPS types.
  • To inform individualized approaches for SCC management in MPS.

Main Methods:

  • Retrospective cohort study of 183 MPS patients (January 1995 - March 2024).
  • Analysis of medical records to identify SCC diagnosis, timing, location, and causes.
  • Statistical comparison of SCC risk and characteristics by MPS type.

Main Results:

  • SCC occurred in 100% of MPS type VI patients, and frequently in types I and IV.
  • Median age at SCC diagnosis was 16.3 years; risk was significantly higher in types I, IV, and VI compared to type II.
  • Ligament thickening and skeletal deformities were common cervical causes, while kyphoscoliosis and disc issues affected the thoracolumbar spine.

Conclusions:

  • Spinal cord compression is a frequent complication in mucopolysaccharidosis, with varying risk and underlying causes depending on the specific MPS type.
  • Enzyme replacement therapy did not significantly alter SCC risk.
  • An individualized approach to early detection and intervention is essential for managing SCC in MPS patients.

Related Concept Videos

Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
4.7K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
2
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
2